BALCX
Price
$40.56
Change
+$0.34 (+0.85%)
Updated
Jun 18 closing price
Net Assets
287.61B
CSGCX
Price
$46.62
Change
+$0.40 (+0.87%)
Updated
Jun 18 closing price
Net Assets
1.49B
Interact to see
Advertisement

BALCX vs CSGCX

BALCX vs CSGCX Comparison Chart in %
View a ticker or compare two or three
VS
BALCX vs. CSGCX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and CSGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 288B vs. CSGCX (1.49B). BALCX pays higher dividends than CSGCX: BALCX (1.16) vs CSGCX (0.63). BALCX was incepted earlier than CSGCX: BALCX (25 years) vs CSGCX (32 years). CSGCX (1.65) is less costly to investors than BALCX (1.30). CSGCX is a more actively managed with annual turnover of: 164.00 vs. BALCX (50.00). BALCX has a lower initial minimum investment than CSGCX: BALCX (250) vs CSGCX (1000). BALCX annual gain was more profitable for investors over the last year : 16.05 vs. CSGCX (9.24). BALCX return over 5 years is better than : 33.55 vs. CSGCX (20.54).
BALCXCSGCXBALCX / CSGCX
Total Expense Ratio1.301.6579%
Annual Report Gross Expense Ratio1.301.6579%
Fund Existence25 years32 years-
Gain YTD9.3883.540265%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B1.49B19,342%
Annual Yield % from dividends1.160.63183%
Returns for 1 year16.059.24174%
Returns for 3 years36.5732.58112%
Returns for 5 years33.5520.54163%
Returns for 10 years78.9771.28111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGRAX48.680.88
+1.84%
Franklin Growth Opportunities A
BSMKX22.080.39
+1.80%
iShares Russell Small/Mid-Cap Idx K
VYMYX19.030.33
+1.76%
Voya MI Dynamic SMID Cap W
SGQAX48.730.71
+1.48%
DWS International Opportunities A
RERFX64.330.57
+0.89%
American Funds EUPAC R5